PVB morphine

PreclinicalSmall molecule

AAssiut University

PVB morphine is one of 7 small molecule programs targeting Analgesic Efficacy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Analgesic EfficacyUnknown status

Analgesic EfficacyPreclinical

Unknown status

Competition

Competitive Landscape

8 competitors in Analgesic Efficacy

#DrugCompanyPhaseTrials

Advil

KKenvue Brands

Approved

4 2

Ultram

WWim Janssens

Approved

1 3

Journavx

Vertex Pharmaceuticals

Phase 3

1 4

Paracetamol

GSK

Phase 3

6 5

Acupan

YYonsei University

Preclinical

1 6

PVB morphine

AAssiut University

Preclinical

1 7

Oxycodone Hcl

PPurdue Pharma LP

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Analgesic Efficacy1 trial

Analgesic Efficacy of Paravertebral Morphine

Unknown status·—·N/A·NCT03379987·120 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for PVB morphine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — PVB morphine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for PVB morphine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assiut University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: AAssiut University

PVB morphine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Analgesic Efficacy1 trial

References

Drug Info

Quick Facts

Related News